BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21098846)

  • 1. Model-predicted performance of second-trimester Down syndrome screening with sonographic prenasal thickness.
    Miguelez J; Moskovitch M; Cuckle H; Zugaib M; Bunduki V; Maymon R
    J Ultrasound Med; 2010 Dec; 29(12):1741-7. PubMed ID: 21098846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second trimester ultrasound prenasal thickness combined with nasal bone length: a new method of Down syndrome screening.
    Maymon R; Levinsohn-Tavor O; Cuckle H; Tovbin Y; Dreazen E; Wiener Y; Herman A
    Prenat Diagn; 2005 Oct; 25(10):906-11. PubMed ID: 16088862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedside estimation of Down syndrome risk from second-trimester ultrasound prenasal thickness.
    Maymon R; Moskovitch M; Levinsohn-Tavor O; Weinraub Z; Herman A; Cuckle H
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):629-33. PubMed ID: 19953559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal bone length, prenasal thickness, prenasal thickness-to-nasal bone length ratio and prefrontal space ratio in second- and third-trimester fetuses with Down syndrome.
    Vos FI; De Jong-Pleij EA; Bakker M; Tromp E; Pajkrt E; Kagan KO; Bilardo CM
    Ultrasound Obstet Gynecol; 2015 Feb; 45(2):211-6. PubMed ID: 24753093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for second-trimester Down syndrome sonographic screening based on facial landmarks and digit length measurement.
    Maymon R; Ushakov F; Waisman D; Cuckle H; Tovbin Y; Herman A
    Ultrasound Obstet Gynecol; 2006 Mar; 27(3):290-5. PubMed ID: 16302282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspicious Prenasal Skin Thickness-to-Nasal Bone Length Ratio: Prevalence and Correlation with Other Markers in Second and Third Trimester Fetuses with Down Syndrome.
    Hagen A; Albig M; Keller T; Stumm M; Entezami M
    Ultraschall Med; 2015 Oct; 36(5):501-6. PubMed ID: 26091004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenasal thickness to nasal bone length ratio: effectiveness as a second or third trimester marker for Down syndrome.
    Tournemire A; Groussolles M; Ehlinger V; Lusque A; Morin M; Benevent JB; Arnaud C; Vayssière C
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():28-32. PubMed ID: 26070124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Serial Measurements of Ultrasound Markers in Second and Third Trimester Down Syndrome Fetuses.
    Vos FI; De Jong-Pleij EA; Bakker M; Tromp E; Bilardo CM
    Fetal Diagn Ther; 2015; 38(1):48-54. PubMed ID: 25661756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's syndrome screening at 11-14 weeks' gestation using prenasal thickness and nasal bone length.
    Manegold-Brauer G; Maymon R; Shor S; Cuckle H; Gembruch U; Geipel A
    Arch Gynecol Obstet; 2019 Apr; 299(4):939-945. PubMed ID: 30739175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of fetal facial markers on a second trimester genetic sonogram in screening for Down syndrome in a high-risk Thai population.
    Pranpanus S; Keatkongkaew K; Suksai M
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):27. PubMed ID: 35016623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial profile markers in second- and third-trimester fetuses with trisomy 18.
    Vos FI; de Jong-Pleij EA; Bakker M; Tromp E; Manten GT; Bilardo CM
    Ultrasound Obstet Gynecol; 2015 Jul; 46(1):66-72. PubMed ID: 25196037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment.
    Orlandi F; Bilardo CM; Campogrande M; Krantz D; Hallahan T; Rossi C; Viora E
    Ultrasound Obstet Gynecol; 2003 Jul; 22(1):36-9. PubMed ID: 12858300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening.
    Odibo AO; Sehdev HM; Gerkowicz S; Stamilio DM; Macones GA
    Am J Obstet Gynecol; 2008 Sep; 199(3):281.e1-5. PubMed ID: 18771983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional ultrasound imaging and measurement of nasal bone length, prenasal thickness and frontomaxillary facial angle in normal second- and third-trimester fetuses.
    Vos FI; De Jong-Pleij EA; Ribbert LS; Tromp E; Bilardo CM
    Ultrasound Obstet Gynecol; 2012 Jun; 39(6):636-41. PubMed ID: 21830246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenasal thickness in trisomy-21 fetuses at 16-24 weeks of gestation.
    Persico N; Borenstein M; Molina F; Azumendi G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):751-4. PubMed ID: 18666090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenasal thickness-to-nasal bone length ratio: a strong and simple second- and third-trimester marker for trisomy 21.
    De Jong-Pleij EA; Vos FI; Ribbert LS; Pistorius LR; Tromp E; Bilardo CM
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):185-90. PubMed ID: 21584886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive role of prenasal thickness and nasal bone for Down syndrome in the second trimester.
    Ozcan T; Özlü T; Allen J; Peterson J; Pressman EK
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):220-4. PubMed ID: 24044955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
    Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.